Voyager Therapeutics
Price & Volume
Stats
See more52W Range | $2.65-$8.28 |
Market Cap | $170.8M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $42.5M |
Revenue Growth (YoY) | -82.4% |
Gross Profit (12 Mos) | -$85.8M |
Diluted EPS | -$1.86 |
News
See moreYahoo Finance • 7 days ago
Voyager Reports Second Quarter 2025 Financial and Operating Results
Yahoo Finance • 27 days ago
Baird reiterates Outperform rating on Voyager Therapeutics stock with $18 price target
Yahoo Finance • 28 days ago
Sector Update: Health Care Stocks Climb Late Afternoon
Yahoo Finance • 28 days ago
Voyager Therapeutics unveils APOE-targeting Alzheimer's therapy program
About
CEO | Dr. Alfred W. Sandrock Jr., M.D., Ph.D. |
CFO | Dr. Nathan D. Jorgensen M.B.A., Ph.D. |
Address | 75 Hayden Avenue, Lexington, MA, United States, 02421 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 172 |
